Soluble E-selectin and intercellular adhesion molecule-1 plasma levels increase during acute myocardial infarction. 1997

F Pellegatta, and G Pizzetti, and Y Lu, and A Radaelli, and D Pomes, and M Carlino, and C Meloni, and G Belotti, and L Galli, and M J Vidal, and S L Chierchia
Laboratory of Cadiovascular Pathophysiology, Istituto Scientifico San Raffaele, Milan, Italy.

Previous studies have shown that adhesion molecules play a crucial role in leukocyte-endothelium interactions that occur during myocardial ischemia and reperfusion. We assessed the plasma levels of the soluble form of E-selectin (sE-selectin) and intercellular adhesion molecule-1 (sICAM-1) in 15 patients with acute myocardial infarction (AMI) and in 15 controls with chronic stable angina. In patients with AMI, the levels of sE-selectin and sICAM-1 increased significantly during the first 8 h after infarction and subsequently decreased. Soluble E-selectin levels were inversely related to the peak plasma levels of creatine kinase-MB (CK-MB), and the time course of their appearance in plasma correlated with that of neutrophil count and plasma D-dimer. In individual patients, peak and mean sICAM-1 levels correlated respectively with plasma D-dimer concentrations and monocyte count, but no correlation were found when their time courses were analyzed. Eight hours after symptom onset, the mean plasma sE-selectin levels were higher in patients with AMI than in those with stable angina, whereas no significant differences were found in mean plasma sICAM-1 levels between the two groups at every time analyzed. In the acute phase of MI (a) sE-selectin and sICAM-1 levels increase during the first 8 h and subsequently decrease; (b) the increase in sE-selectin probably reflects activation of endothelial cells, correlates with other inflammatory and coagulation parameters, and is inversely related to the degree of myocardial damage; and (c) sICAM-1 plasma levels do not represent a good marker of "cell activation" because they reflect activation of different cells and may be affected by different conditions.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D003402 Creatine Kinase A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins. Creatine Phosphokinase,ADP Phosphocreatine Phosphotransferase,ATP Creatine Phosphotransferase,Macro-Creatine Kinase,Creatine Phosphotransferase, ATP,Kinase, Creatine,Macro Creatine Kinase,Phosphocreatine Phosphotransferase, ADP,Phosphokinase, Creatine,Phosphotransferase, ADP Phosphocreatine,Phosphotransferase, ATP Creatine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D018799 Intercellular Adhesion Molecule-1 A cell-surface ligand involved in leukocyte adhesion and inflammation. Its production is induced by gamma-interferon and it is required for neutrophil migration into inflamed tissue. Antigens, CD54,CD54 Antigens,ICAM-1,CD54 Antigen,Antigen, CD54,Intercellular Adhesion Molecule 1
D019040 E-Selectin Cell adhesion molecule and CD antigen that mediates neutrophil, monocyte, and memory T-cell adhesion to cytokine-activated endothelial cells. E-selectin recognizes sialylated carbohydrate groups related to the Lewis X or Lewis A family. Antigens, CD62E,CD62E Antigens,E Selectin,ELAM-1,Endothelial Leukocyte Adhesion Molecule-1,LECAM-2,CD62E Antigen,Endothelial Leukocyte Adhesion Molecule 1,Antigen, CD62E,Selectin, E

Related Publications

F Pellegatta, and G Pizzetti, and Y Lu, and A Radaelli, and D Pomes, and M Carlino, and C Meloni, and G Belotti, and L Galli, and M J Vidal, and S L Chierchia
September 1997, Japanese circulation journal,
F Pellegatta, and G Pizzetti, and Y Lu, and A Radaelli, and D Pomes, and M Carlino, and C Meloni, and G Belotti, and L Galli, and M J Vidal, and S L Chierchia
January 1999, Nephron,
F Pellegatta, and G Pizzetti, and Y Lu, and A Radaelli, and D Pomes, and M Carlino, and C Meloni, and G Belotti, and L Galli, and M J Vidal, and S L Chierchia
April 1996, The British journal of dermatology,
F Pellegatta, and G Pizzetti, and Y Lu, and A Radaelli, and D Pomes, and M Carlino, and C Meloni, and G Belotti, and L Galli, and M J Vidal, and S L Chierchia
February 2005, Coronary artery disease,
F Pellegatta, and G Pizzetti, and Y Lu, and A Radaelli, and D Pomes, and M Carlino, and C Meloni, and G Belotti, and L Galli, and M J Vidal, and S L Chierchia
January 1996, Clinical and experimental immunology,
F Pellegatta, and G Pizzetti, and Y Lu, and A Radaelli, and D Pomes, and M Carlino, and C Meloni, and G Belotti, and L Galli, and M J Vidal, and S L Chierchia
November 2010, Chest,
F Pellegatta, and G Pizzetti, and Y Lu, and A Radaelli, and D Pomes, and M Carlino, and C Meloni, and G Belotti, and L Galli, and M J Vidal, and S L Chierchia
January 2009, Lung,
F Pellegatta, and G Pizzetti, and Y Lu, and A Radaelli, and D Pomes, and M Carlino, and C Meloni, and G Belotti, and L Galli, and M J Vidal, and S L Chierchia
July 1998, British journal of cancer,
F Pellegatta, and G Pizzetti, and Y Lu, and A Radaelli, and D Pomes, and M Carlino, and C Meloni, and G Belotti, and L Galli, and M J Vidal, and S L Chierchia
September 2000, The Journal of rheumatology,
F Pellegatta, and G Pizzetti, and Y Lu, and A Radaelli, and D Pomes, and M Carlino, and C Meloni, and G Belotti, and L Galli, and M J Vidal, and S L Chierchia
January 1995, International journal of microcirculation, clinical and experimental,
Copied contents to your clipboard!